ConductScience.org, home

Paper9103439

Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.

Vergelli M and 8 others. J Immunol, 1997. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. Papers, record 9103439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9103439

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.
PubMed
Journal
J Immunol
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2006-11-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vergelli MM
2Hemmer BB
3Kalbus MM
4Vogt ABA B
5Ling NN
6Conlon PP
7Coligan JEJ E
8McFarland HH
9Martin RR

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphocyte ActivationMajor topic
PeptidesMajor topic
T-LymphocytesMajor topic
Amino Acid Sequence
Humans
Ligands
Molecular Sequence Data

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
37409132The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer.Front Immunol2023https://conductscience.org/library/papers/37409132PubMed
33091337HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.Cell2020https://conductscience.org/library/papers/33091337PubMed
26401510Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions.Ann Clin Transl Neurol2015https://conductscience.org/library/papers/26401510PubMed
22888134Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.J Immunol2012https://conductscience.org/library/papers/22888134PubMed
18998128Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?Cancer Immunol Immunother2009https://conductscience.org/library/papers/18998128PubMed
16906394An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity.Cancer Immunol Immunother2007https://conductscience.org/library/papers/16906394PubMed
11898528T cells, cytokines, and autoantigens in multiple sclerosis.Curr Neurol Neurosci Rep2001https://conductscience.org/library/papers/11898528PubMed
10319877Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.Ann Neurol1999https://conductscience.org/library/papers/10319877PubMed
9802984In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis.J Exp Med1998https://conductscience.org/library/papers/9802984PubMed
9492986Activation of autoreactive T cells by peptides from human pathogens.Curr Opin Immunol1997https://conductscience.org/library/papers/9492986PubMed
9419364Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9419364PubMed
9151902Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.J Exp Med1997https://conductscience.org/library/papers/9151902PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9103439

GET https://conductscience.org/api/papers/v1/9103439/authors